Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Boasting in-license distribution model, Chinese EOC Pharma bags $32M series B funding for oncology products
8 years ago
Financing
As National Party Congress concludes, China’s FDA seeks to write widely-anticipated drug reforms into law
8 years ago
Abbas Hussain swings from top GSK pharma post to powerhouse Chinese private equity player C-Bridge
8 years ago
People
Financing
A China biotech unicorn scores big with $150M-plus IPO on Nasdaq, stock rockets up
8 years ago
Financing
Top 5 biopharma trends: The long-awaited biopharma revolution in China has arrived — don’t lose out
8 years ago
As China biotech booms, Fidelity group rolls out $250M fund with a big focus on drug R&D
8 years ago
Financing
Celgene-partnered Antengene preps new China deals as $21M round lands
8 years ago
Pharma
With a big stake in hand, Samantha Du files for $115M IPO for Zai Lab
8 years ago
Financing
China biotech bags a $57M round as it races to complete R&D, manufacturing site
8 years ago
Financing
10 years and $100M-plus later, GSK shutters a China R&D site during a major pipeline overhaul
8 years ago
R&D
Pharma
Celgene joins the PD-1 checkpoint club, bagging BeiGene drug with $413M down and $1B on the table
9 years ago
Pharma
With deep ties to China, Vivace exits stealth mode with a lead cancer program, platform and $40M
9 years ago
Financing
Startups
New Chinese VC leads $10M round for a Harvard spinout looking to industrialize platelet manufacturing
9 years ago
Pharma
Nanjing Legend wows ASCO researchers with early data on a BCMA-targeted CAR-T contender
9 years ago
R&D
China biotech startup InventisBio bags a $19M round for early-stage R&D
9 years ago
Startups
Ge Li melds WuXi VC with Frontline, creating an $800M trans-Pacific powerhouse fund now hunting fresh biotech capital
9 years ago
Financing
Ge Li’s fast-growing WuXi Biologics sets the stage for a $513M IPO
9 years ago
Financing
Zai Lab CEO Samantha Du is raising a $150M biotech fund
9 years ago
Financing
China has a $1.45B plan to build up its biotech hubs — and officials are moving fast
9 years ago
Shanghai-based EpimAb Bio grows global roots with $25M A round and a key assist by Robert Kamen
9 years ago
Financing
With a big cash assist from local officials, BeiGene is building a $330M biologics facility in China
9 years ago
Outsourcing
Pharma
FibroGen, AstraZeneca ready China application as anemia drug scores in two pivotal studies
9 years ago
R&D
Pharma
Innovent Biologics sets a biotech record in China with $260M raise for PhIII work
9 years ago
China backers help bankroll a $100M mega-round as an influential antibody engineer readies trials
9 years ago
First page
Previous page
26
27
28
29
30
Next page
Last page